Skip to content
Evan Levine, PsyBio Therapeutics episode artwork

Aug 18, 2021 20 min

Evan Levine, PsyBio Therapeutics

from Psychedelic Spotlight Podcast Hosted by David Flores, Global Trac Solutions Inc., PsyBio Therapeutics, Evan Levine, Psychedelic Spotlight

In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health issues and other disorders. In our conversation with Evan, we get the opportunity to learn more about the unique therapeutic solutions PsyBio is currently focused on developing, and we gain a more concise understanding of the value the company is establishing for itself through its evolving intellectual property portfolio of biosynthetic psychoactive compounds. *To learn more about PsyBio Therapeutics and the work they’re doing, visit their website: PsyBioLife.com *Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com Instagram: @PsycSpotlight Twitter: @PsycSpotlight Facebook: PsychedelicSpotlight YouTube: PsychedelicSpotlight LinkedIn: Psychedelic-Spotlight *This interview was recorded on August 10, 2021.

Episode details come from the podcast's RSS feed.

Embed this episode

Chairman & CEO of PsyBio Therapeutics, Evan Levine, shares why PsyBio doesn't use magic mushrooms to make psilocybin medicine.

Ready to play

Evan Levine, PsyBio Therapeutics

0:00 20:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Psychedelic Spotlight Podcast?

This episode is 20 minutes long.

When was this Psychedelic Spotlight Podcast episode published?

This episode was published on August 18, 2021.

Can I download this Psychedelic Spotlight Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.